Openbookopenbook
Equity
DGX
+0.0 · +0.00%
USD · NYSE

Quest Diagnostics Incorporated(DGX) Stock Analysis | Healthcare

USD --+0.00%
Reward44Moderate
Risk31Moderate
75%Data
Revenue growing 10% YoY
Capital Destroyer
Market Cap:26.97Bn
ⓘ
Reward Rating
44
Moderate
Reward Assessment
75% data coverage
Bottom 25% of stocksView factors
ⓘ
Risk Rating
31
Moderate
Risk Assessment
1 metric flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on DGX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for DGX, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $245.87.

What is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States.

DGX · Verdict

Moderate reward · moderate risk

DGX stands out on volatility and cash flow, but watch the growth signal.

Based on 88% data coverage

DGX · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Cash flow79/100

    12% free-cash-flow margin

Watchouts 2

  • Growth38/100

    Rev +3.7% CAGR · earnings +1.6%

  • Balance sheet44/100

    Interest covered 5.9×

Model-based scoring. For information only — not financial advice.

What is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 26.97B, and a P/E ratio of 26.0x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with momentum and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Diagnostics & Research names that are close enough in size to make side-by-side comparison useful.

LHLarge Cap / 25.8B market cap
Laboratory Corporation of America Holdings
Compare
MTDLarge Cap / 28.4B market cap
Mettler-Toledo International Inc
Compare
GHLarge Cap / 22.9B market cap
Guardant Health Inc
Compare
Company Information
SectorHealthcare
IndustryDiagnostics & Research
Market Cap26.97B
P/E Ratio25.9713
Dividend Yield1.38%
Beta0.548
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
414,919 shares
$3.1M
0
6-9months
49,164 shares
$1.9M
0
9-12months
794,461 shares
$18.0M
0
3 disclosures without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.